SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001626199-21-000145
Filing Date
2021-11-10
Accepted
2021-11-10 17:17:38
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 s-3_resale2021pipe.htm S-3 280488
2 EX-5.1 alpn-ex51_resale2021xpipe.htm EX-5.1 13663
3 EX-23.1 alpn-ex231_resale2021pipe.htm EX-23.1 2422
4 image_0.jpg GRAPHIC 7532
5 image_1.jpg GRAPHIC 74541
  Complete submission text file 0001626199-21-000145.txt   410862
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260971 | Film No.: 211397847
SIC: 2834 Pharmaceutical Preparations